How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.
"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...
How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between...
"Artificial Intelligence is a tool that really levels up and creates almost like an equity for everybody to participate and, when used effectively, to...